Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo

Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo

Purpose: Glioblastoma (GBM) is the most common primary brain tumour and one of the deadliest cancers. In addition to late diagnosis and inadequate treatment, the extremely low survival rate is also due to the lack of appropriate therapeutic biomarkers and corresponding therapeutic agents. One of the...

Full description

Bibliographic Details
Main Authors: Alja Zottel, Metka Novak, Neja Šamec, Bernarda Majc, Sara Colja, Mojca Katrašnik, Miloš Vittori, Barbara Hrastar, Ana Rotter, Andrej Porčnik, Tamara Lah Turnšek, Radovan Komel, Barbara Breznik, Ivana Jovčevska
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cancers
Subjects:
glioblastoma
vimentin
nanobody
invasion
EMT
Online Access:https://www.mdpi.com/2072-6694/15/3/573

Internet

https://www.mdpi.com/2072-6694/15/3/573

Similar Items